NeoHack Secures Two Patents for Formulations and Methods of Achieving Pain Relief

  • Home
  • Newest Patents
  • Next Generation Treatment
  • Dr. Brown's Blog
  • NeoHack
  • Potential Uses
  • Contact and License
  • Patient Case Studies
  • Resources
  • Alzheimer's Research
  • Understand the Market
  • More
    • Home
    • Newest Patents
    • Next Generation Treatment
    • Dr. Brown's Blog
    • NeoHack
    • Potential Uses
    • Contact and License
    • Patient Case Studies
    • Resources
    • Alzheimer's Research
    • Understand the Market
  • Home
  • Newest Patents
  • Next Generation Treatment
  • Dr. Brown's Blog
  • NeoHack
  • Potential Uses
  • Contact and License
  • Patient Case Studies
  • Resources
  • Alzheimer's Research
  • Understand the Market

NeoHack USA Market Opportunity Exceeds $1.9 Trillion

NeoHack USA Market Opportunity Exceeds $1.9 TrillionNeoHack USA Market Opportunity Exceeds $1.9 TrillionNeoHack USA Market Opportunity Exceeds $1.9 TrillionNeoHack USA Market Opportunity Exceeds $1.9 Trillion

Pain Research

Koivisto et al, TRPA1 Agonists for Pain Relief (pdf)Download
Gerbino et al, Spilanthol from Oleracea Lowers Intracellular levels . . . (pdf)Download
Ceccarelli et al, The CB2 Agonist B-Caryophyllene in Male and Female rats . . . (pdf)Download

Copyright © 2023 NeoHack Life Sciences, LLC - All Rights Reserved


Powered by

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close